@misc{10481/98015,
year = {2022},
month = {5},
url = {https://hdl.handle.net/10481/98015},
abstract = {Objectives: Compliance in outpatients with gastrointestinal (GI) malabsorption is key in nutritional treatment.
The objective of this study was to assess compliance in patients with GI impairment and malnutrition
taking a high-calorie, high-protein, peptide-based oral nutritional supplement (ONS-PBD).
Methods: A prospective, multicenter, observational study was conducted in 19 medical sites in Spain where
ONS-PBD were prescribed as standard of care. Patients consumed ONS-PBD daily for 12 wk. Compliance was
calculated as the percentage consumed of the prescribed amount of ONS per day.
Results: A total of 90 adult patients were included in the study, of whom 64 completed the 12-wk regimine.
Mean compliance was 78.8% § 24.5%. Risk of malnutrition decreased in 56.3% of patients at 12 wk, as measured
with the malnutrition universal screening tool. A reduction in abdominal pain was observed and stool consistency improved, with a mean of 54.7% and 27.5%, respectively. Improvements in quality of life and a decrease in percentage of patients with severe functional impairment were observed. Conclusions: These data show that ONS-PBD compliance in malnourished patients with GI symptoms is high, reducing GI symptoms and improving patients’ nutritional status.},
organization = {Abbott Nutrition},
publisher = {Elsevier},
title = {Relationship between nutritional treatment compliance and nutritional status improvements in patients with gastrointestinal impairment taking an oral peptide based supplement},
doi = {10.1016/j.nut.2022.111734},
author = {Fernández Soto, María Luisa},
}